Mineralys Therapeutics, INC. (MLYS) — SC 13D/A Filings
All SC 13D/A filings from Mineralys Therapeutics, INC.. Browse 1 SC 13D/A reports with AI-powered summaries and risk analysis.
SC 13D/A Filings (1)
-
Samsara BioCapital Amends Mineralys Therapeutics Stake
— Feb 12, 2024 Risk: medium
Samsara BioCapital, L.P. filed an amended Schedule 13D on February 12, 2024, regarding its ownership in Mineralys Therapeutics, Inc. This amendment, filed by Sa
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX